Severe eosinophilic asthma and mepolizumab

Research output: Contribution to journalComment/debate

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)528-529
Number of pages2
JournalThe Lancet. Respiratory medicine
Volume4
Issue number7
Early online date10 May 2016
DOIs
Publication statusPublished - Jul 2016

Cite this

Severe eosinophilic asthma and mepolizumab. / Walsh, Garry M.

In: The Lancet. Respiratory medicine, Vol. 4, No. 7, 07.2016, p. 528-529.

Research output: Contribution to journalComment/debate

@article{bb7e8c0a92ba4ee997bed42af8922558,
title = "Severe eosinophilic asthma and mepolizumab",
author = "Walsh, {Garry M}",
year = "2016",
month = "7",
doi = "10.1016/S2213-2600(16)30103-5",
language = "English",
volume = "4",
pages = "528--529",
journal = "The Lancet. Respiratory medicine",
issn = "2213-2600",
publisher = "Elsevier Limited",
number = "7",

}

TY - JOUR

T1 - Severe eosinophilic asthma and mepolizumab

AU - Walsh, Garry M

PY - 2016/7

Y1 - 2016/7

U2 - 10.1016/S2213-2600(16)30103-5

DO - 10.1016/S2213-2600(16)30103-5

M3 - Comment/debate

VL - 4

SP - 528

EP - 529

JO - The Lancet. Respiratory medicine

JF - The Lancet. Respiratory medicine

SN - 2213-2600

IS - 7

ER -